Becton Dickinson Articles
US FDA fast-track for Sanofi Pasteur's KB001A; orphan status for Teva/Xenon's XEN402; second BD Simplist product approved
23 April 2013
CHMP gives thumbs up to Sanofi's Intanza flu vacc
12 January 2009
Affymetrix launches new GeneChip RNA profiling kits
25 April 2005
Enzo settles patent dispute with Chugai and bioMerieux
17 March 2003
Becton Dickinson expands in Spain
25 February 2002
Immucor net income tops $1 million
15 October 2001
Aerogen settles inhaler lawsuit with Becton Dickinson
4 October 2001
EPO revokes Roche patent on PCR technology
4 June 2001
Nippon BD takes over Clontech Labs Japan
28 March 2001
Becton Dickinson to cut 1,000 jobs
27 September 2000
MoliChem completes Ph I study of CF drug
1 June 2000
NHS to make injection pens available on NHS
10 February 2000
Qiagen forms JV with Becton Dickinson
2 September 1999
Qiagen forms JV with Becton Dickinson
31 August 1999
Becton Dickinson to acquire Clontech Labs in revised deal
12 August 1999
Cortecs Losses Deepen; Confident About Future
15 September 1998
CellPro To Continue Making Products Outside USA
10 February 1998
Quidel Settlement
18 June 1997
CellPro: Stem Cell Patent Infringement Case Continues
10 April 1997
Speculation On Roche-Bayer Diagnostics Alliance
26 March 1997
US Jury Awards $2.3m Against CellPro In Patent Dispute
17 March 1997
Becton Dickinson Raises Investment In India
25 November 1996
Quadrant L6.3M Placing
17 June 1996
Celsis Appointment
6 May 1996
Becton Dickinson Appointment
12 February 1996
Major M&As in 1995 As UK Industry Consolidates
8 January 1996
Becton Dickinson China health project
11 September 1995
CellPro Challenged In CD34 Antibody Patent Dispute
31 July 1995
Becton settle allergations
26 June 1995
ICN Pharma Buys Becton Unit
15 May 1995
Becton Shareholders Reassured On Future
27 February 1995
Becton Dickinson Joins Singapore Plan
28 November 1994
Becton Dickinson Sells Stake
28 November 1994
US Quarterly Results News Round-Up
28 November 1994
Merck & Co Chairman Earnings
22 August 1994
Strong Gains By US Firms In 2nd Quarter
1 August 1994
OUTSIDER TO REPLACE VAGELOS AT MERCK & CO
20 June 1994
US 1ST QTR RESULTS LEAN TOWARDS GROWTH
30 May 1994
STRONG DOLLAR WEAKENS US 1993 RESULTS
31 January 1994
BECTON DICKINSON APPOINTMENTS
10 January 1994
US 3rd QUARTER RESULTS - SOME IMPROVEMENT
6 December 1993
BECTON DICKINSON UPS PRODUCTION
4 October 1993
NICOTINE PATCH COs SUFFER DECLINE IN US SALES
2 August 1993
BECTON SUES UNILEVER AND AHP
28 June 1993
BECTON SUCCESS ON PRODUCT QUALITY
1 March 1993
RECORD RESULTS FROM US PHARMA MAJORS
1 February 1993
GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs
3 August 1992
GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN
4 May 1992
QUIDEL AND BECTON DICKINSON DEAL
20 April 1992
ROCHE'S MICROBIOLOGY DIAGNOSTIC BUSINESS SALE
13 April 1992
BIO-MERIEUX NEEDS NEW FINANCE
17 February 1992
Showing 1-57 of 57 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
